Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R0UJ
|
||||
| Former ID |
DAP000580
|
||||
| Drug Name |
Pargyline
|
||||
| Synonyms |
Benzylmethylpropargylamine; Benzylmethylpropynylamine; Eudatin; Eutron; Methylbenzylpropynylamine; Paragyline; Pargilina; Pargylamine; Pargylin; Pargylinum; Supirdyl; A 19120; MO 911; Pargilina [INN-Spanish]; Pargyline (INN); Pargyline [INN:BAN]; Pargylinum [INN-Latin]; Benzyl-methyl-2-propinylamin; Benzyl-methyl-2-propinylamin [Czech]; N-Methyl-N-benzylpropynylamine; N-Methyl-N-propargylbenzylamine; N-Methyl-N-2-propynylbenzylamine; N-Benzyl-N-methyl-2-propynylamine; N-Benzyl-N-methyl-2-propyn-1; N-Benzyl-N-methyl-2-propyn-1-amine; N-benzyl-N-methylprop-2-yn-1-amine; N-methyl-N-(phenylmethyl)prop-2-yn-1-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Moderate to severe hypertension [ICD10:I10-I16] | Approved | [551871] | ||
| Therapeutic Class |
Antihypertensive Agents
|
||||
| Company |
Abbott Laboratories Pharmaceutical Products Div
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H13N
|
||||
| InChI |
InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3
|
||||
| InChIKey |
DPWPWRLQFGFJFI-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 555-57-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9618, 794485, 3133951, 4905557, 8152879, 10527079, 11111668, 11111669, 11335228, 11360467, 11363535, 11366097, 11368659, 11371759, 11374057, 11376821, 11461439, 11466211, 11467331, 11484993, 11485762, 11488855, 11490356, 11492284, 11494455, 15171008, 24897164, 29223774, 46507368, 47216615, 47290968, 47736296, 47810590, 48034936, 48034937, 48034938, 48034939, 48334307, 48416382, 49698875, 49893341, 50100328, 50104247, 50735625, 56369647, 57322398, 85177273, 85787887, 85856309, 90340843
|
||||
| SuperDrug ATC ID |
C02KC01
|
||||
| SuperDrug CAS ID |
cas=000555577
|
||||
| Target and Pathway | |||||
| Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [537499] | |
| KEGG Pathway | Glycine, serine and threonine metabolism | ||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tyrosine metabolism | |||||
| Phenylalanine metabolism | |||||
| Tryptophan metabolism | |||||
| Drug metabolism - cytochrome P450 | |||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Dopaminergic synapse | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Alcoholism | |||||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.